Azithromycin and tezacaftor/ivacaftor is associated with first-degree heart block in an adult with cystic fibrosis
- 4 August 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 20 (2), e19-e21
- https://doi.org/10.1016/j.jcf.2020.07.016
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del AlleleThe New England Journal of Medicine, 2019
- Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delThe New England Journal of Medicine, 2017
- Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trialThorax, 2002